The peripheral lymph node homing receptor, LECAM-1, is involved in CD18-independent adhesion of human neutrophils to endothelium.
The binding of polymorphonuclear granulocytes (PMN) to activated vascular endothelium is a crucial step in the recruitment of PMN to an inflammatory site. Studies employing cytokine-activated endothelium in culture have shown that PMN binding involves the CD18 family of leukocyte integrins, but also CD18-independent adhesion mechanism(s) on PMN that have not been defined. We unify here two previously disparate approaches to study cell adhesion events between endothelial cells and leukocytes. We show that antibodies to human LECAM-1, the peripheral lymph node homing receptor that is also expressed on PMN, partially inhibit the adhesion of human PMN not only to HEV in frozen sections of lymph node tissue, but also to cytokine-activated human umbilical vein endothelium in vitro. Inhibition with anti-LECAM-1 antibodies and anti-CD18 antibodies is additive. Furthermore, the anti-LECAM-1 antibodies inhibit the adhesion of CD18-deficient PMN to cytokine activated human endothelial cells. These findings indicate that LECAM-1 and CD18-mediated binding mechanisms are independent, and act coordinately or sequentially to mediate PMN attachment to cytokine activated endothelium.
Hallmann
R
R
Department of Pathology, Stanford University School of Medicine, CA 94305.
Jutila
M A
MA
Smith
C W
CW
Anderson
D C
DC
Kishimoto
T K
TK
Butcher
E C
EC
D018821:CD18 Antigens; D002448:Cell Adhesion / Q000276:immunology*; D015815:Cell Adhesion Molecules / Q000502:physiology*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000276:immunology; D006801:Humans; D008198:Lymph Nodes / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology*; D016028:Receptors, Leukocyte-Adhesion / Q000276:immunology*; D016201:Receptors, Lymphocyte Homing / Q000276:immunology*
D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D016028:Receptors, Leukocyte-Adhesion; D016201:Receptors, Lymphocyte Homing